First-In-Human Study Of Orally Administered CoV2-OGEN1 In Healthy Subjects
Clinical trial NCT04893512 · COMPLETED
Trial details
- NCT number
- NCT04893512
- Sponsor
- Syneos Health
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2021-06-30
- Primary completion
- 2022-11-11
- Enrollment
- 45
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.